Menu
Back to Journals » Cancer Management and Research » Volume 13
Original Research
Cost-Effectiveness Analysis of Camrelizumab Immunotherapy versus Docetaxel or Irinotecan Chemotherapy as Second-Line Therapy for Advanced or Metastatic Esophageal Squamous Cell Carcinoma
| Total article views | HTML views | PDF downloads | Totals | ||
|---|---|---|---|---|---|
| 4,266 | Dovepress* | 3,831+ | 194 | 4,025 | |
| PubMed Central* | 435 | 195 | 630 | ||
| Totals | 4,266 | 389 | 4,655 | ||
| *Since 2 November 2021 | |||||
| Total mentioned | Delicious | Others | |||
|---|---|---|---|---|---|
| 2 | 0 | 0 | 0 | 1 | 1 |
View citations on PubMed Central and Google Scholar